Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days

New feature: Introducing the Finviz Matrix

Genelux Corporation

Contributing Author

Recent Articles by Genelux Corporation

Sep-09	Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy GNLX GlobeNewswire
Aug-13	Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates GNLX GlobeNewswire
Jun-30	Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi-Vec in Ovarian Cancer GNLX GlobeNewswire
May-07	Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates GNLX GNLX +9.89% GlobeNewswire
Mar-19	Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates GNLX GNLX -5.51% GlobeNewswire
Feb-18	Genelux Corporation to Participate in Upcoming Conferences GNLX GlobeNewswire
Jan-12	Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners GNLX -5.36% GlobeNewswire
Jan-08	Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock GNLX -19.76% GlobeNewswire
Jan-07	Genelux Corporation Announces Proposed Public Offering of Common Stock GNLX GlobeNewswire
Jan-05	Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials GNLX -23.52% GlobeNewswire
Jan-02	Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer GNLX GlobeNewswire
Nov-26	Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference GNLX +5.67% GlobeNewswire
Nov-05	Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates GNLX GNLX -32.40% GlobeNewswire
Sep-02	Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference GNLX GlobeNewswire
Aug-07	Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates GNLX -6.96% GNLX -5.69% GlobeNewswire
Jul-07	Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development GNLX GlobeNewswire
May-06	Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates GNLX -7.17% GlobeNewswire
May-01	Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference GNLX -9.85% GNLX +8.45% GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)